Market Place
Sourcing Support
Aucta debuts generic Vimpat
11 Mar 2024 //
DRUG STORE NEWS
Aucta Pharma Launches First Once-Daily Lacosamide ER Capsule
26 Feb 2024 //
PR NEWSWIRE
Aucta announced FDA approval of a generic version of Trileptal oral suspension
05 Dec 2022 //
PR NEWSWIRE
Aucta announces FDA approval of a generic version of Perforomist Inhalation
01 Dec 2022 //
PRNEWSWIRE
Aucta`s Generic Oxcarbazepine Receives Approval in the U.S.
30 Nov 2022 //
FDA
Aucta`s Generic Formoterol Fumarate Receives Approval in the U.S.
25 Nov 2022 //
FDA
Aucta Pharma and Oakrum Pharma Announce Launch of Generic Version of JADENU
14 Jun 2021 //
PRNEWSWIRE
Oakrum Pharma and Aucta Pharma Announce U.S. FDA Approval of Generic Version
22 Mar 2021 //
PRNEWSWIRE
FDA Action Alert: Eton Pharmaceuticals and Vertex Pharmaceuticals
20 Mar 2020 //
BIOSPACE
Oakrum Pharma Announces the Launch of Pyrimethamine 25mg Tablets in US
12 Mar 2020 //
PTCOMMUNITY
FDA Says No To Epilepsy Drug, IMV Advances COVID-19 Vaccine, ISEE Delays Study
11 Mar 2020 //
NASDAQ
Eton Receives NDA Acceptance for Oral Liquid Seizure Medication
02 Sep 2019 //
CONTRACT PHARMA
Eton Announces Second Quarter Financial Results and Highlights Business Progress
06 Aug 2019 //
GLOBENEWSWIRE
Aucta Pharmaceuticals filing for epilepsy drug accepted by US FDA
01 Aug 2019 //
SPGLOBAL
Eton Pharmaceuticals Announces Fda Acceptance Of New Drug Application For Et-105
01 Aug 2019 //
PHARMALIVE
Aucta partners with Fosun Pharma to market the FDA-approved Vigabatrin
26 Jul 2019 //
GLOBENEWSWIRE
Aucta Pharmaceuticals Announces Licensing of Vigabatrin for Oral Solution in China
25 Jul 2019 //
WORLDPHARMATODAY
Aucta Receives its First Approval & Launches Vigabatrin for Brand Name Vigadrone™
16 Jul 2019 //
GLOBENEWSWIRE
Aucta Pharmaceuticals Announces Licensing of Lamotrigine New Drug Application
27 Jun 2019 //
GLOBE NEWSWIRE
Aucta & Oakrum Announce Product Development and Commercialization Partnership
19 Feb 2019 //
GLOBENEWSWIRE
Oakrum Pharma & Aucta Pharma Announce Product Development Partnership
19 Feb 2019 //
PR NEWSWIRE
Catalent to formulate vigabatrin into novel dosage form through agreement
06 Aug 2018 //
EPMMAGAZINE
Aucta Receives its First Product Approval and Launches Vigabatrin for Oral Solution Under the Brand Name Vigadrone™
16 Jul 2018 //
PRESS RELEASE
Aucta Pharma`s Generic Vigabatrin Receives Approval in US
26 Jun 2018 //
FDA
Aucta Receives its First Product Approval and Launches Vigabatrin
16 Apr 2018 //
GLOBENEWSWIRE
Sunnylife Pharma is newest tenant at NJEDA’s CCIT
06 Apr 2018 //
ROI
Aucta Receives its First Product Approval and Launches Vigabatrin
03 Sep 2017 //
GLOBENEWSWIRE
FDA Says No To Epilepsy Drug, IMV Advances COVID-19 Vaccine, ISEE Delays Study
19 Mar 2017 //
NASDAQ
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.